Regeneron Reaches Drug-Pricing Deal with Administration
- April 24, 2026
- Written by AHLA Legal Staff
Regeneron is the latest major drug manufacturer to reach a deal with the Trump administration as part of the ongoing effort to align drug prices in the United States with those of other developed nations.
ARTICLE TAGS
You must be logged in to access this content.